Header Logo

Connection

JOSEPH JANKOVIC to Tremor

Back to Details
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Tremor.
JOSEPH JANKOVIC
Connection Strength
10.314
Tremor
  1. Functional Neurological Disorders Among Patients With Tremor. J Neuropsychiatry Clin Neurosci. 2025; 37(1):61-66.
    View in: PubMed
    Score: 0.845
  2. Botulinum toxin for the treatment of tremor. Parkinsonism Relat Disord. 2019 06; 63:31-41.
    View in: PubMed
    Score: 0.578
  3. Reader response: The nature of postural tremor in Parkinson disease. Neurology. 2018 10 09; 91(15):723.
    View in: PubMed
    Score: 0.566
  4. Essential Tremor. N Engl J Med. 2018 08 09; 379(6):595.
    View in: PubMed
    Score: 0.559
  5. Botulinum Toxin for the Treatment of Hand Tremor. Toxins (Basel). 2018 07 19; 10(7).
    View in: PubMed
    Score: 0.557
  6. Parkinson's disease tremors and serotonin. Brain. 2018 03 01; 141(3):624-626.
    View in: PubMed
    Score: 0.543
  7. Botulinum Toxin for the Treatment of Tremor and Tics. Semin Neurol. 2016 Feb; 36(1):54-63.
    View in: PubMed
    Score: 0.471
  8. Parkinson disease subtypes. JAMA Neurol. 2014 Apr; 71(4):499-504.
    View in: PubMed
    Score: 0.414
  9. Hereditary chin tremor in Parkinson's disease. Clin Neurol Neurosurg. 2007 Nov; 109(9):784-5.
    View in: PubMed
    Score: 0.259
  10. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor. J Neurol Sci. 2007 Sep 15; 260(1-2):199-203.
    View in: PubMed
    Score: 0.258
  11. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. Expert Rev Neurother. 2007 Jun; 7(6):637-47.
    View in: PubMed
    Score: 0.258
  12. Psychogenic tremor: long-term outcome. CNS Spectr. 2006 Jul; 11(7):501-8.
    View in: PubMed
    Score: 0.242
  13. Botulinum toxin treatment in parkinsonism. J Neurol Sci. 2024 01 15; 456:122810.
    View in: PubMed
    Score: 0.202
  14. Peripherally-induced Movement Disorders: An Update. Tremor Other Hyperkinet Mov (N Y). 2023; 13:8.
    View in: PubMed
    Score: 0.193
  15. The etiopathogenetic and pathophysiological spectrum of parkinsonism. J Neurol Sci. 2022 Feb 15; 433:120012.
    View in: PubMed
    Score: 0.174
  16. Parkinsonism and tremor syndromes. J Neurol Sci. 2022 Feb 15; 433:120018.
    View in: PubMed
    Score: 0.174
  17. Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson's Disease in a Movement Disorders Clinic. Tremor Other Hyperkinet Mov (N Y). 2021 03 29; 11:12.
    View in: PubMed
    Score: 0.168
  18. Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application. Neurosurgery. 2001 Mar; 48(3):535-41; discussion 541-3.
    View in: PubMed
    Score: 0.167
  19. Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity. Parkinsonism Relat Disord. 2021 03; 84:105-111.
    View in: PubMed
    Score: 0.166
  20. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 01 26; 96(4):e563-e574.
    View in: PubMed
    Score: 0.163
  21. Postural Directionality and Head Tremor in Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2020; 10.
    View in: PubMed
    Score: 0.155
  22. Functional gait disorders, clinical phenomenology, and classification. Neurol Sci. 2020 Apr; 41(4):911-915.
    View in: PubMed
    Score: 0.153
  23. Essential tremor-plus: a controversial new concept. Lancet Neurol. 2020 03; 19(3):266-270.
    View in: PubMed
    Score: 0.153
  24. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Nov; 67(5):646-50.
    View in: PubMed
    Score: 0.152
  25. Head tremor at disease onset: an ataxic phenotype of cervical dystonia. J Neurol. 2019 Aug; 266(8):1844-1851.
    View in: PubMed
    Score: 0.147
  26. Diagnosis and Management of Parkinson's Disease. Semin Neurol. 2017 04; 37(2):118-126.
    View in: PubMed
    Score: 0.128
  27. Familial essential tremor in 4 kindreds. Prospects for genetic mapping. Arch Neurol. 1997 Mar; 54(3):289-94.
    View in: PubMed
    Score: 0.127
  28. Examiner manoeuvres 'sensory tricks' in functional (psychogenic) movement disorders. J Neurol Neurosurg Psychiatry. 2017 05; 88(5):453-455.
    View in: PubMed
    Score: 0.125
  29. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord. 1996 May; 11(3):250-6.
    View in: PubMed
    Score: 0.119
  30. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery. 1995 Oct; 37(4):680-6; discussion 686-7.
    View in: PubMed
    Score: 0.115
  31. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology. 1995 Apr; 45(4):645-8.
    View in: PubMed
    Score: 0.111
  32. Peripherally induced tremor and parkinsonism. Arch Neurol. 1995 Mar; 52(3):263-70.
    View in: PubMed
    Score: 0.110
  33. Myorhythmia: phenomenology, etiology, and treatment. Mov Disord. 2015 Feb; 30(2):171-9.
    View in: PubMed
    Score: 0.108
  34. Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve. 1993 Sep; 16(9):904-10.
    View in: PubMed
    Score: 0.099
  35. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon. 2013 Jun 01; 67:94-114.
    View in: PubMed
    Score: 0.095
  36. Tardive tremor. Mov Disord. 1992; 7(1):53-7.
    View in: PubMed
    Score: 0.088
  37. Essential tremor: clinical correlates in 350 patients. Neurology. 1991 Feb; 41(2 ( Pt 1)):234-8.
    View in: PubMed
    Score: 0.083
  38. Orthostatic tremor: an association with essential tremor. Mov Disord. 1991; 6(1):60-4.
    View in: PubMed
    Score: 0.083
  39. Peripherally induced movement disorders. Neurol Clin. 2009 Aug; 27(3):821-32, vii.
    View in: PubMed
    Score: 0.075
  40. Disease-oriented approach to botulinum toxin use. Toxicon. 2009 Oct; 54(5):614-23.
    View in: PubMed
    Score: 0.072
  41. Dystonia and tremor induced by peripheral trauma: predisposing factors. J Neurol Neurosurg Psychiatry. 1988 Dec; 51(12):1512-9.
    View in: PubMed
    Score: 0.071
  42. Genetic study of an American family with DYT3 dystonia (lubag). Neurosci Lett. 2008 Dec 26; 448(2):180-3.
    View in: PubMed
    Score: 0.071
  43. Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology. 1988 Apr; 38(4):522-7.
    View in: PubMed
    Score: 0.068
  44. Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain. 2006 Sep; 129(Pt 9):2318-31.
    View in: PubMed
    Score: 0.060
  45. Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members. J Neurol Sci. 2024 Mar 15; 458:122925.
    View in: PubMed
    Score: 0.051
  46. Longitudinal predictors of health-related quality of life in isolated dystonia. J Neurol. 2024 Feb; 271(2):852-863.
    View in: PubMed
    Score: 0.050
  47. Isolated Cervical Dystonia: Diagnosis and Classification. Mov Disord. 2023 08; 38(8):1367-1378.
    View in: PubMed
    Score: 0.048
  48. COVID19-associated new-onset movement disorders: a follow-up study. J Neurol. 2023 May; 270(5):2409-2415.
    View in: PubMed
    Score: 0.048
  49. Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiology. EBioMedicine. 2022 Nov; 85:104290.
    View in: PubMed
    Score: 0.047
  50. The Conundrum of Dystonia in Essential Tremor Patients: How does One Classify these Cases? Tremor Other Hyperkinet Mov (N Y). 2022; 12:15.
    View in: PubMed
    Score: 0.045
  51. Head tremor in cervical dystonia: Quantifying severity with computer vision. J Neurol Sci. 2022 Mar 15; 434:120154.
    View in: PubMed
    Score: 0.044
  52. Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions. Nat Rev Neurol. 2022 03; 18(3):145-157.
    View in: PubMed
    Score: 0.044
  53. Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion. Eur J Neurol. 2021 12; 28(12):3999-4009.
    View in: PubMed
    Score: 0.043
  54. Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia? Tremor Other Hyperkinet Mov (N Y). 2021 06 23; 11:21.
    View in: PubMed
    Score: 0.043
  55. Head tremor and pain in cervical dystonia. J Neurol. 2021 May; 268(5):1945-1950.
    View in: PubMed
    Score: 0.041
  56. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology. 1998 Oct; 51(4):1063-9.
    View in: PubMed
    Score: 0.035
  57. Thalamic surgery for movement disorders. Adv Neurol. 1997; 74:221-33.
    View in: PubMed
    Score: 0.031
  58. Post-traumatic movement disorders: central and peripheral mechanisms. Neurology. 1994 Nov; 44(11):2006-14.
    View in: PubMed
    Score: 0.027
  59. Cocaine-related movement disorders. Mov Disord. 1993 Apr; 8(2):175-8.
    View in: PubMed
    Score: 0.024
  60. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord. 2013 May; 28(5):668-70.
    View in: PubMed
    Score: 0.024
  61. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord. 2013 Apr; 28(4):543-7.
    View in: PubMed
    Score: 0.024
  62. Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991 Jul; 41(7):1088-91.
    View in: PubMed
    Score: 0.021
  63. Therapeutic uses of botulinum toxin. N Engl J Med. 1991 Apr 25; 324(17):1186-94.
    View in: PubMed
    Score: 0.021
  64. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990 Oct; 40(10):1529-34.
    View in: PubMed
    Score: 0.020
  65. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990 May; 83(5):525-32.
    View in: PubMed
    Score: 0.020
  66. Cranial-cervical dyskinesias: an overview. Adv Neurol. 1988; 49:1-13.
    View in: PubMed
    Score: 0.017
  67. Alcohol dehydrogenase polymorphism and Parkinson's disease. Neurosci Lett. 2001 Jun 01; 305(1):70-2.
    View in: PubMed
    Score: 0.011
  68. Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Clin Neuropharmacol. 1996 Apr; 19(2):157-64.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.